[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2014 Analysis of Leading Life Science Intermediates Companies Technological Know-How

November 2013 | 35 pages | ID: C1E9957CB0CEN
Venture Planning Group

US$ 1,960.00 US$ 2,450.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This new report from Venture Planning Group provides technological know-how of leading life science intermediates companies.

The report presents:
  • Internally developed and acquired technologies, and related capabilities.
  • Proprietary technologies and patent litigations.
The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep, and Rhodia. Contains 35 pages
1. BASF
2. CAMBREX
3. CLARIANT
4. DOWPHARMA
5. DSM
6. EVONIK
7. LANXESS
8. LONZA
9. NOVASEP
10. RHODIA

For each company, the report presents:

Internally developed and acquired technologies, and related capabilities.
Proprietary technologies and patent litigations.


More Publications